206 related articles for article (PubMed ID: 15637639)
1. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Panayi F; Colussi-Mas J; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
[TBL] [Abstract][Full Text] [Related]
2. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
3. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to amphetamine psychostimulant effect: A key role for ventral tegmental area neurotensin type 2 receptors and MAP kinase pathway.
Voyer D; Einsiedel J; Gmeiner P; Lévesque D; Rompré PP
Addict Biol; 2021 Sep; 26(5):e13008. PubMed ID: 33491227
[TBL] [Abstract][Full Text] [Related]
5. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
Tolliver BK; Ho LB; Fox LM; Berger SP
J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
7. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
Bauco P; Rompré PP
Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
[TBL] [Abstract][Full Text] [Related]
8. Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
Casti P; Marchese G; Casu G; Ruiu S; Pani L
Neuropharmacology; 2004 Jul; 47(1):128-35. PubMed ID: 15165840
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
Rompré P; Perron S
Neuropharmacology; 2000 Jul; 39(10):1880-92. PubMed ID: 10884569
[TBL] [Abstract][Full Text] [Related]
10. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
Vezina P; Queen AL
Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464
[TBL] [Abstract][Full Text] [Related]
11. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Cáceda R; Binder EB; Kinkead B; Nemeroff CB
Schizophr Res; 2012 Apr; 136(1-3):88-95. PubMed ID: 22104138
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
Reynolds SM; Geisler S; Bérod A; Zahm DS
Eur J Neurosci; 2006 Jul; 24(1):188-96. PubMed ID: 16882016
[TBL] [Abstract][Full Text] [Related]
13. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
14. Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats.
Champtiaux N; Kalivas PW; Bardo MT
Behav Brain Res; 2006 Mar; 168(1):120-6. PubMed ID: 16313978
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin afferents of the ventral tegmental area in the rat: [1] re-examination of their origins and [2] responses to acute psychostimulant and antipsychotic drug administration.
Geisler S; Zahm DS
Eur J Neurosci; 2006 Jul; 24(1):116-34. PubMed ID: 16882012
[TBL] [Abstract][Full Text] [Related]
16. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
Kalivas PW; Alesdatter JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):486-95. PubMed ID: 8229779
[TBL] [Abstract][Full Text] [Related]
17. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
Bjijou Y; Stinus L; Le Moal M; Cador M
J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects.
Chen JC; Liang KW; Huang EY
Synapse; 2001 Mar; 39(3):239-48. PubMed ID: 11169772
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.
Johnston CE; Herschel DJ; Lasek AW; Hammer RP; Nikulina EM
Neuropharmacology; 2015 Feb; 89():325-34. PubMed ID: 25446676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
